BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 16786240)

  • 21. Strategies for designing GPCR-focused libraries and screening sets.
    Jimonet P; Jäger R
    Curr Opin Drug Discov Devel; 2004 May; 7(3):325-33. PubMed ID: 15216936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NMR spectroscopy tools for structure-aided drug design.
    Homans SW
    Angew Chem Int Ed Engl; 2004 Jan; 43(3):290-300. PubMed ID: 14705081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allosteric approaches to the targeting of G-protein-coupled receptors for novel drug discovery: a critical assessment.
    Raddatz R; Schaffhauser H; Marino MJ
    Biochem Pharmacol; 2007 Aug; 74(3):383-91. PubMed ID: 17572390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The study of G-protein coupled receptor oligomerization with computational modeling and bioinformatics.
    Filizola M; Weinstein H
    FEBS J; 2005 Jun; 272(12):2926-38. PubMed ID: 15955053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling small molecule-compound binding to G-protein-coupled receptors.
    Vaidehi N; Pease JE; Horuk R
    Methods Enzymol; 2009; 460():263-88. PubMed ID: 19446730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional selectivity of GPCR ligand stereoisomers: new pharmacological opportunities.
    Seifert R; Dove S
    Mol Pharmacol; 2009 Jan; 75(1):13-8. PubMed ID: 19001067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alternative drug discovery approaches for orphan GPCRs.
    Levoye A; Jockers R
    Drug Discov Today; 2008 Jan; 13(1-2):52-8. PubMed ID: 18190864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. G protein-coupled receptor dimers: functional consequences, disease states and drug targets.
    Dalrymple MB; Pfleger KD; Eidne KA
    Pharmacol Ther; 2008 Jun; 118(3):359-71. PubMed ID: 18486226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of GPCR structures in drug design.
    Congreve M; Langmead C; Marshall FH
    Adv Pharmacol; 2011; 62():1-36. PubMed ID: 21907905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 'allosteric modulator' SCH-202676 disrupts G protein-coupled receptor function via sulphydryl-sensitive mechanisms.
    Lewandowicz AM; Vepsäläinen J; Laitinen JT
    Br J Pharmacol; 2006 Feb; 147(4):422-9. PubMed ID: 16402041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Definition of the G protein-coupled receptor transmembrane bundle binding pocket and calculation of receptor similarities for drug design.
    Gloriam DE; Foord SM; Blaney FE; Garland SL
    J Med Chem; 2009 Jul; 52(14):4429-42. PubMed ID: 19537715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of ligand-receptor systems by high-resolution solid-state NMR: recent progress and perspectives.
    Luca S; Heise H; Lange A; Baldus M
    Arch Pharm (Weinheim); 2005 Jun; 338(5-6):217-28. PubMed ID: 15938000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NMR in the acceleration of drug discovery.
    Sem DS; Pellecchia M
    Curr Opin Drug Discov Devel; 2001 Jul; 4(4):479-92. PubMed ID: 11727313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computational overview of GPCR gene universe to support reverse chemical genomics study.
    Suwa M; Ono Y
    Methods Mol Biol; 2009; 577():41-54. PubMed ID: 19718507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamics and flexibility of G-protein-coupled receptor conformations and their relevance to drug design.
    Vaidehi N
    Drug Discov Today; 2010 Nov; 15(21-22):951-7. PubMed ID: 20831898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding the ligand-receptor-G protein ternary complex for GPCR drug discovery.
    Ratnala VR; Kobilka B
    Methods Mol Biol; 2009; 552():67-77. PubMed ID: 19513642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral delivery of G protein-coupled receptor modulators: an explanation for the observed class difference.
    Beaumont K; Schmid E; Smith DA
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3658-64. PubMed ID: 15982884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenomics of G protein-coupled receptor signaling: insights from health and disease.
    Thompson MD; Cole DE; Jose PA
    Methods Mol Biol; 2008; 448():77-107. PubMed ID: 18370232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective interface detection: mapping binding site contacts in membrane proteins by NMR spectroscopy.
    Kiihne SR; Creemers AF; de Grip WJ; Bovee-Geurts PH; Lugtenburg J; de Groot HJ
    J Am Chem Soc; 2005 Apr; 127(16):5734-5. PubMed ID: 15839640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.